The global market for Chemical API CDMO was valued at US$ 25750 million in the year 2024 and is projected to reach a revised size of US$ 43109 million by 2031, growing at a CAGR of 7.6% during the forecast period.

Chemical API CDMO Market

Chemical API CDMO, or Contract Research and Manufacturing Organization, provides pharmaceutical companies with customized R&D and manufacturing services for active pharmaceutical ingredients (APIs) and related intermediates from preclinical to commercialization stages. Its services encompass process route development and optimization, analytical method establishment and validation, pilot-scale and intermediate-scale production, process safety assessment, and support for large-scale production and registration applications in compliance with Good Manufacturing Practices (GMP). This model, through specialized division of labor, helps clients reduce R&D costs, shorten development cycles, address the challenges of complex chemical synthesis and production scale-up, and ensure supply chain reliability and compliance. It is a key enabling link in the supply chain for innovative chemical drugs and complex generic drugs.

The cost structure of a Chemical API CDMO primarily includes human resources investment in R&D and process optimization, depreciation and energy consumption of GMP-compliant production facilities, procurement of key materials, and strict environmental and quality control costs. Its gross profit margin typically ranges from 25% to 45%, depending on the complexity of the technology, production scale, and capacity utilization. Projects with technological barriers, such as highly active APIs and continuous flow processes, can command significant premiums, while standardized products produced at scale rely on cost control and supply chain efficiency to maintain profits.

The global landscape of Chemical API CDMO presents a "dual-core, diversified evolution" pattern. The Asia-Pacific region, represented by China and India, is the world's largest production capacity center and supply chain hub. Leveraging its mature chemical engineering foundation, cost advantages, and continuously improving compliance levels, it dominates the mid-to-back-end large-scale production market. Europe and North America maintain technological leadership in cutting-edge process development, complex molecule production, and early-stage clinical projects, particularly in the high-activity, high-value-added API sector. Currently, the global industrial chain is undergoing rapid restructuring. The need for supply chain security and regional autonomy is driving a trend towards decentralized and near-shore production capacity. Meanwhile, technological innovations such as green chemistry and continuous manufacturing, along with regulatory upgrades in emerging markets, are jointly shaping a more resilient, efficient, and sustainable new industry ecosystem for the future.

This report aims to provide a comprehensive presentation of the global market for Chemical API CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemical API CDMO.

The Chemical API CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chemical API CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, by Business Stage and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chemical API CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chemical API CDMO Market Report

Report Metric	Details
Report Name	Chemical API CDMO Market
Accounted market size in year	US$ 25750 million
Forecasted market size in 2031	US$ 43109 million
CAGR	7.6%
Base Year	year
Forecasted years	2026 - 2031
Segment by Type	Small Molecule CDMO Macromolecule CDMO Cell Gene Therapy (CGT) CDMO
Segment by Business Stage	Early-stage R&D CDMO Clinical Stage CDMO Commercial Production CDMO
Segment by Product Technology	Bulk/Standard API CDMO Specialty API CDMO
Segment by Application	Pharmaceutical and Biotechnology Companies Research and Academic Institutions Hospital Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Flamma Group, HAS Healthcare, Asymchem, Recipharm, Pierre Fabre, Pfizer CentreOne, Axplora, Lonza, MAI CDMO, BioVectra, Curia, AGC Pharma Chemicals, Olon Group, Evonik Health Care, Teva Active Pharmaceutical Ingredients
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Business Stage etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chemical API CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Chemical API CDMO Market growing?

Ans: The Chemical API CDMO Market witnessing a CAGR of 7.6% during the forecast period 2026-2031.

What is the Chemical API CDMO Market size in 2031?

Ans: The Chemical API CDMO Market size in 2031 will be US$ 43109 million.

Who are the main players in the Chemical API CDMO Market report?

Ans: The main players in the Chemical API CDMO Market are Flamma Group, HAS Healthcare, Asymchem, Recipharm, Pierre Fabre, Pfizer CentreOne, Axplora, Lonza, MAI CDMO, BioVectra, Curia, AGC Pharma Chemicals, Olon Group, Evonik Health Care, Teva Active Pharmaceutical Ingredients

What are the Application segmentation covered in the Chemical API CDMO Market report?

Ans: The Applications covered in the Chemical API CDMO Market report are Pharmaceutical and Biotechnology Companies, Research and Academic Institutions, Hospital, Others

What are the Type segmentation covered in the Chemical API CDMO Market report?

Ans: The Types covered in the Chemical API CDMO Market report are Small Molecule CDMO, Macromolecule CDMO, Cell Gene Therapy (CGT) CDMO

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chemical API CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Small Molecule CDMO

1.2.3 Macromolecule CDMO

1.2.4 Cell Gene Therapy (CGT) CDMO

1.3 Market by Business Stage

1.3.1 Global Chemical API CDMO Market Size Growth Rate by Business Stage: 2020 VS 2024 VS 2031

1.3.2 Early-stage R&D CDMO

1.3.3 Clinical Stage CDMO

1.3.4 Commercial Production CDMO

1.4 Market by Product Technology

1.4.1 Global Chemical API CDMO Market Size Growth Rate by Product Technology: 2020 VS 2024 VS 2031

1.4.2 Bulk/Standard API CDMO

1.4.3 Specialty API CDMO

1.5 Market by Application

1.5.1 Global Chemical API CDMO Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Pharmaceutical and Biotechnology Companies

1.5.3 Research and Academic Institutions

1.5.4 Hospital

1.5.5 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Chemical API CDMO Market Perspective (2020-2031)

2.2 Global Chemical API CDMO Growth Trends by Region

2.2.1 Global Chemical API CDMO Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Chemical API CDMO Historic Market Size by Region (2020-2025)

2.2.3 Chemical API CDMO Forecasted Market Size by Region (2026-2031)

2.3 Chemical API CDMO Market Dynamics

2.3.1 Chemical API CDMO Industry Trends

2.3.2 Chemical API CDMO Market Drivers

2.3.3 Chemical API CDMO Market Challenges

2.3.4 Chemical API CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Chemical API CDMO Players by Revenue

3.1.1 Global Top Chemical API CDMO Players by Revenue (2020-2025)

3.1.2 Global Chemical API CDMO Revenue Market Share by Players (2020-2025)

3.2 Global Top Chemical API CDMO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Chemical API CDMO Revenue

3.4 Global Chemical API CDMO Market Concentration Ratio

3.4.1 Global Chemical API CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chemical API CDMO Revenue in 2024

3.5 Global Key Players of Chemical API CDMO Head office and Area Served

3.6 Global Key Players of Chemical API CDMO, Product and Application

3.7 Global Key Players of Chemical API CDMO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Chemical API CDMO Breakdown Data by Type

4.1 Global Chemical API CDMO Historic Market Size by Type (2020-2025)

4.2 Global Chemical API CDMO Forecasted Market Size by Type (2026-2031)

5 Chemical API CDMO Breakdown Data by Application

5.1 Global Chemical API CDMO Historic Market Size by Application (2020-2025)

5.2 Global Chemical API CDMO Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Chemical API CDMO Market Size (2020-2031)

6.2 North America Chemical API CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Chemical API CDMO Market Size by Country (2020-2025)

6.4 North America Chemical API CDMO Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Chemical API CDMO Market Size (2020-2031)

7.2 Europe Chemical API CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Chemical API CDMO Market Size by Country (2020-2025)

7.4 Europe Chemical API CDMO Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Chemical API CDMO Market Size (2020-2031)

8.2 Asia-Pacific Chemical API CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Chemical API CDMO Market Size by Region (2020-2025)

8.4 Asia-Pacific Chemical API CDMO Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Chemical API CDMO Market Size (2020-2031)

9.2 Latin America Chemical API CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Chemical API CDMO Market Size by Country (2020-2025)

9.4 Latin America Chemical API CDMO Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Chemical API CDMO Market Size (2020-2031)

10.2 Middle East & Africa Chemical API CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Chemical API CDMO Market Size by Country (2020-2025)

10.4 Middle East & Africa Chemical API CDMO Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Flamma Group

11.1.1 Flamma Group Company Details

11.1.2 Flamma Group Business Overview

11.1.3 Flamma Group Chemical API CDMO Introduction

11.1.4 Flamma Group Revenue in Chemical API CDMO Business (2020-2025)

11.1.5 Flamma Group Recent Development

11.2 HAS Healthcare

11.2.1 HAS Healthcare Company Details

11.2.2 HAS Healthcare Business Overview

11.2.3 HAS Healthcare Chemical API CDMO Introduction

11.2.4 HAS Healthcare Revenue in Chemical API CDMO Business (2020-2025)

11.2.5 HAS Healthcare Recent Development

11.3 Asymchem

11.3.1 Asymchem Company Details

11.3.2 Asymchem Business Overview

11.3.3 Asymchem Chemical API CDMO Introduction

11.3.4 Asymchem Revenue in Chemical API CDMO Business (2020-2025)

11.3.5 Asymchem Recent Development

11.4 Recipharm

11.4.1 Recipharm Company Details

11.4.2 Recipharm Business Overview

11.4.3 Recipharm Chemical API CDMO Introduction

11.4.4 Recipharm Revenue in Chemical API CDMO Business (2020-2025)

11.4.5 Recipharm Recent Development

11.5 Pierre Fabre

11.5.1 Pierre Fabre Company Details

11.5.2 Pierre Fabre Business Overview

11.5.3 Pierre Fabre Chemical API CDMO Introduction

11.5.4 Pierre Fabre Revenue in Chemical API CDMO Business (2020-2025)

11.5.5 Pierre Fabre Recent Development

11.6 Pfizer CentreOne

11.6.1 Pfizer CentreOne Company Details

11.6.2 Pfizer CentreOne Business Overview

11.6.3 Pfizer CentreOne Chemical API CDMO Introduction

11.6.4 Pfizer CentreOne Revenue in Chemical API CDMO Business (2020-2025)

11.6.5 Pfizer CentreOne Recent Development

11.7 Axplora

11.7.1 Axplora Company Details

11.7.2 Axplora Business Overview

11.7.3 Axplora Chemical API CDMO Introduction

11.7.4 Axplora Revenue in Chemical API CDMO Business (2020-2025)

11.7.5 Axplora Recent Development

11.8 Lonza

11.8.1 Lonza Company Details

11.8.2 Lonza Business Overview

11.8.3 Lonza Chemical API CDMO Introduction

11.8.4 Lonza Revenue in Chemical API CDMO Business (2020-2025)

11.8.5 Lonza Recent Development

11.9 MAI CDMO

11.9.1 MAI CDMO Company Details

11.9.2 MAI CDMO Business Overview

11.9.3 MAI CDMO Chemical API CDMO Introduction

11.9.4 MAI CDMO Revenue in Chemical API CDMO Business (2020-2025)

11.9.5 MAI CDMO Recent Development

11.10 BioVectra

11.10.1 BioVectra Company Details

11.10.2 BioVectra Business Overview

11.10.3 BioVectra Chemical API CDMO Introduction

11.10.4 BioVectra Revenue in Chemical API CDMO Business (2020-2025)

11.10.5 BioVectra Recent Development

11.11 Curia

11.11.1 Curia Company Details

11.11.2 Curia Business Overview

11.11.3 Curia Chemical API CDMO Introduction

11.11.4 Curia Revenue in Chemical API CDMO Business (2020-2025)

11.11.5 Curia Recent Development

11.12 AGC Pharma Chemicals

11.12.1 AGC Pharma Chemicals Company Details

11.12.2 AGC Pharma Chemicals Business Overview

11.12.3 AGC Pharma Chemicals Chemical API CDMO Introduction

11.12.4 AGC Pharma Chemicals Revenue in Chemical API CDMO Business (2020-2025)

11.12.5 AGC Pharma Chemicals Recent Development

11.13 Asymchem

11.13.1 Asymchem Company Details

11.13.2 Asymchem Business Overview

11.13.3 Asymchem Chemical API CDMO Introduction

11.13.4 Asymchem Revenue in Chemical API CDMO Business (2020-2025)

11.13.5 Asymchem Recent Development

11.14 Olon Group

11.14.1 Olon Group Company Details

11.14.2 Olon Group Business Overview

11.14.3 Olon Group Chemical API CDMO Introduction

11.14.4 Olon Group Revenue in Chemical API CDMO Business (2020-2025)

11.14.5 Olon Group Recent Development

11.15 Evonik Health Care

11.15.1 Evonik Health Care Company Details

11.15.2 Evonik Health Care Business Overview

11.15.3 Evonik Health Care Chemical API CDMO Introduction

11.15.4 Evonik Health Care Revenue in Chemical API CDMO Business (2020-2025)

11.15.5 Evonik Health Care Recent Development

11.16 Teva Active Pharmaceutical Ingredients

11.16.1 Teva Active Pharmaceutical Ingredients Company Details

11.16.2 Teva Active Pharmaceutical Ingredients Business Overview

11.16.3 Teva Active Pharmaceutical Ingredients Chemical API CDMO Introduction

11.16.4 Teva Active Pharmaceutical Ingredients Revenue in Chemical API CDMO Business (2020-2025)

11.16.5 Teva Active Pharmaceutical Ingredients Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Asymchem

Recipharm

Axplora

Lonza

Teva Active Pharmaceutical Ingredients

List of Tables

Table 1. Global Chemical API CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Small Molecule CDMO

Table 3. Key Players of Macromolecule CDMO

Table 4. Key Players of Cell Gene Therapy (CGT) CDMO

Table 5. Global Chemical API CDMO Market Size Growth Rate by Business Stage (US$ Million): 2020 VS 2024 VS 2031

Table 6. Key Players of Early-stage R&D CDMO

Table 7. Key Players of Clinical Stage CDMO

Table 8. Key Players of Commercial Production CDMO

Table 9. Global Chemical API CDMO Market Size Growth Rate by Product Technology (US$ Million): 2020 VS 2024 VS 2031

Table 10. Key Players of Bulk/Standard API CDMO

Table 11. Key Players of Specialty API CDMO

Table 12. Global Chemical API CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 13. Global Chemical API CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 14. Global Chemical API CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 15. Global Chemical API CDMO Market Share by Region (2020-2025)

Table 16. Global Chemical API CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 17. Global Chemical API CDMO Market Share by Region (2026-2031)

Table 18. Chemical API CDMO Market Trends

Table 19. Chemical API CDMO Market Drivers

Table 20. Chemical API CDMO Market Challenges

Table 21. Chemical API CDMO Market Restraints

Table 22. Global Chemical API CDMO Revenue by Players (2020-2025) & (US$ Million)

Table 23. Global Chemical API CDMO Market Share by Players (2020-2025)

Table 24. Global Top Chemical API CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemical API CDMO as of 2024)

Table 25. Ranking of Global Top Chemical API CDMO Companies by Revenue (US$ Million) in 2024

Table 26. Global 5 Largest Players Market Share by Chemical API CDMO Revenue (CR5 and HHI) & (2020-2025)

Table 27. Global Key Players of Chemical API CDMO, Headquarters and Area Served

Table 28. Global Key Players of Chemical API CDMO, Product and Application

Table 29. Global Key Players of Chemical API CDMO, Date of Enter into This Industry

Table 30. Mergers & Acquisitions, Expansion Plans

Table 31. Global Chemical API CDMO Market Size by Type (2020-2025) & (US$ Million)

Table 32. Global Chemical API CDMO Revenue Market Share by Type (2020-2025)

Table 33. Global Chemical API CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 34. Global Chemical API CDMO Revenue Market Share by Type (2026-2031)

Table 35. Global Chemical API CDMO Market Size by Application (2020-2025) & (US$ Million)

Table 36. Global Chemical API CDMO Revenue Market Share by Application (2020-2025)

Table 37. Global Chemical API CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 38. Global Chemical API CDMO Revenue Market Share by Application (2026-2031)

Table 39. North America Chemical API CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. North America Chemical API CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 41. North America Chemical API CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 42. Europe Chemical API CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Europe Chemical API CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 44. Europe Chemical API CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 45. Asia-Pacific Chemical API CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 46. Asia-Pacific Chemical API CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 47. Asia-Pacific Chemical API CDMO Market Size by Region (2026-2031) & (US$ Million)

Table 48. Latin America Chemical API CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Latin America Chemical API CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 50. Latin America Chemical API CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 51. Middle East & Africa Chemical API CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 52. Middle East & Africa Chemical API CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 53. Middle East & Africa Chemical API CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 54. Flamma Group Company Details

Table 55. Flamma Group Business Overview

Table 56. Flamma Group Chemical API CDMO Product

Table 57. Flamma Group Revenue in Chemical API CDMO Business (2020-2025) & (US$ Million)

Table 58. Flamma Group Recent Development

Table 59. HAS Healthcare Company Details

Table 60. HAS Healthcare Business Overview

Table 61. HAS Healthcare Chemical API CDMO Product

Table 62. HAS Healthcare Revenue in Chemical API CDMO Business (2020-2025) & (US$ Million)

Table 63. HAS Healthcare Recent Development

Table 64. Asymchem Company Details

Table 65. Asymchem Business Overview

Table 66. Asymchem Chemical API CDMO Product

Table 67. Asymchem Revenue in Chemical API CDMO Business (2020-2025) & (US$ Million)

Table 68. Asymchem Recent Development

Table 69. Recipharm Company Details

Table 70. Recipharm Business Overview

Table 71. Recipharm Chemical API CDMO Product

Table 72. Recipharm Revenue in Chemical API CDMO Business (2020-2025) & (US$ Million)

Table 73. Recipharm Recent Development

Table 74. Pierre Fabre Company Details

Table 75. Pierre Fabre Business Overview

Table 76. Pierre Fabre Chemical API CDMO Product

Table 77. Pierre Fabre Revenue in Chemical API CDMO Business (2020-2025) & (US$ Million)

Table 78. Pierre Fabre Recent Development

Table 79. Pfizer CentreOne Company Details

Table 80. Pfizer CentreOne Business Overview

Table 81. Pfizer CentreOne Chemical API CDMO Product

Table 82. Pfizer CentreOne Revenue in Chemical API CDMO Business (2020-2025) & (US$ Million)

Table 83. Pfizer CentreOne Recent Development

Table 84. Axplora Company Details

Table 85. Axplora Business Overview

Table 86. Axplora Chemical API CDMO Product

Table 87. Axplora Revenue in Chemical API CDMO Business (2020-2025) & (US$ Million)

Table 88. Axplora Recent Development

Table 89. Lonza Company Details

Table 90. Lonza Business Overview

Table 91. Lonza Chemical API CDMO Product

Table 92. Lonza Revenue in Chemical API CDMO Business (2020-2025) & (US$ Million)

Table 93. Lonza Recent Development

Table 94. MAI CDMO Company Details

Table 95. MAI CDMO Business Overview

Table 96. MAI CDMO Chemical API CDMO Product

Table 97. MAI CDMO Revenue in Chemical API CDMO Business (2020-2025) & (US$ Million)

Table 98. MAI CDMO Recent Development

Table 99. BioVectra Company Details

Table 100. BioVectra Business Overview

Table 101. BioVectra Chemical API CDMO Product

Table 102. BioVectra Revenue in Chemical API CDMO Business (2020-2025) & (US$ Million)

Table 103. BioVectra Recent Development

Table 104. Curia Company Details

Table 105. Curia Business Overview

Table 106. Curia Chemical API CDMO Product

Table 107. Curia Revenue in Chemical API CDMO Business (2020-2025) & (US$ Million)

Table 108. Curia Recent Development

Table 109. AGC Pharma Chemicals Company Details

Table 110. AGC Pharma Chemicals Business Overview

Table 111. AGC Pharma Chemicals Chemical API CDMO Product

Table 112. AGC Pharma Chemicals Revenue in Chemical API CDMO Business (2020-2025) & (US$ Million)

Table 113. AGC Pharma Chemicals Recent Development

Table 114. Asymchem Company Details

Table 115. Asymchem Business Overview

Table 116. Asymchem Chemical API CDMO Product

Table 117. Asymchem Revenue in Chemical API CDMO Business (2020-2025) & (US$ Million)

Table 118. Asymchem Recent Development

Table 119. Olon Group Company Details

Table 120. Olon Group Business Overview

Table 121. Olon Group Chemical API CDMO Product

Table 122. Olon Group Revenue in Chemical API CDMO Business (2020-2025) & (US$ Million)

Table 123. Olon Group Recent Development

Table 124. Evonik Health Care Company Details

Table 125. Evonik Health Care Business Overview

Table 126. Evonik Health Care Chemical API CDMO Product

Table 127. Evonik Health Care Revenue in Chemical API CDMO Business (2020-2025) & (US$ Million)

Table 128. Evonik Health Care Recent Development

Table 129. Teva Active Pharmaceutical Ingredients Company Details

Table 130. Teva Active Pharmaceutical Ingredients Business Overview

Table 131. Teva Active Pharmaceutical Ingredients Chemical API CDMO Product

Table 132. Teva Active Pharmaceutical Ingredients Revenue in Chemical API CDMO Business (2020-2025) & (US$ Million)

Table 133. Teva Active Pharmaceutical Ingredients Recent Development

Table 134. Research Programs/Design for This Report

Table 135. Key Data Information from Secondary Sources

Table 136. Key Data Information from Primary Sources

Table 137. Authors List of This Report

List of Figures

Figure 1. Chemical API CDMO Picture

Figure 2. Global Chemical API CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Chemical API CDMO Market Share by Type: 2024 VS 2031

Figure 4. Small Molecule CDMO Features

Figure 5. Macromolecule CDMO Features

Figure 6. Cell Gene Therapy (CGT) CDMO Features

Figure 7. Global Chemical API CDMO Market Size Comparison by Business Stage (2020-2031) & (US$ Million)

Figure 8. Early-stage R&D CDMO Features

Figure 9. Clinical Stage CDMO Features

Figure 10. Commercial Production CDMO Features

Figure 11. Global Chemical API CDMO Market Size Comparison by Product Technology (2020-2031) & (US$ Million)

Figure 12. Bulk/Standard API CDMO Features

Figure 13. Specialty API CDMO Features

Figure 14. Global Chemical API CDMO Market Size by Application (2020-2031) & (US$ Million)

Figure 15. Global Chemical API CDMO Market Share by Application: 2024 VS 2031

Figure 16. Pharmaceutical and Biotechnology Companies Case Studies

Figure 17. Research and Academic Institutions Case Studies

Figure 18. Hospital Case Studies

Figure 19. Others Case Studies

Figure 20. Chemical API CDMO Report Years Considered

Figure 21. Global Chemical API CDMO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 22. Global Chemical API CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 23. Global Chemical API CDMO Market Share by Region: 2024 VS 2031

Figure 24. Global Chemical API CDMO Market Share by Players in 2024

Figure 25. Global Chemical API CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 26. The Top 10 and 5 Players Market Share by Chemical API CDMO Revenue in 2024

Figure 27. North America Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. North America Chemical API CDMO Market Share by Country (2020-2031)

Figure 29. United States Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Canada Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Europe Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Europe Chemical API CDMO Market Share by Country (2020-2031)

Figure 33. Germany Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. France Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. U.K. Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Italy Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Russia Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Ireland Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Asia-Pacific Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Chemical API CDMO Market Share by Region (2020-2031)

Figure 41. China Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Japan Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. South Korea Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Southeast Asia Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. India Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Australia & New Zealand Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Latin America Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Latin America Chemical API CDMO Market Share by Country (2020-2031)

Figure 49. Mexico Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Brazil Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Middle East & Africa Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Middle East & Africa Chemical API CDMO Market Share by Country (2020-2031)

Figure 53. Israel Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. UAE Chemical API CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Flamma Group Revenue Growth Rate in Chemical API CDMO Business (2020-2025)

Figure 57. HAS Healthcare Revenue Growth Rate in Chemical API CDMO Business (2020-2025)

Figure 58. Asymchem Revenue Growth Rate in Chemical API CDMO Business (2020-2025)

Figure 59. Recipharm Revenue Growth Rate in Chemical API CDMO Business (2020-2025)

Figure 60. Pierre Fabre Revenue Growth Rate in Chemical API CDMO Business (2020-2025)

Figure 61. Pfizer CentreOne Revenue Growth Rate in Chemical API CDMO Business (2020-2025)

Figure 62. Axplora Revenue Growth Rate in Chemical API CDMO Business (2020-2025)

Figure 63. Lonza Revenue Growth Rate in Chemical API CDMO Business (2020-2025)

Figure 64. MAI CDMO Revenue Growth Rate in Chemical API CDMO Business (2020-2025)

Figure 65. BioVectra Revenue Growth Rate in Chemical API CDMO Business (2020-2025)

Figure 66. Curia Revenue Growth Rate in Chemical API CDMO Business (2020-2025)

Figure 67. AGC Pharma Chemicals Revenue Growth Rate in Chemical API CDMO Business (2020-2025)

Figure 68. Asymchem Revenue Growth Rate in Chemical API CDMO Business (2020-2025)

Figure 69. Olon Group Revenue Growth Rate in Chemical API CDMO Business (2020-2025)

Figure 70. Evonik Health Care Revenue Growth Rate in Chemical API CDMO Business (2020-2025)

Figure 71. Teva Active Pharmaceutical Ingredients Revenue Growth Rate in Chemical API CDMO Business (2020-2025)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Small Molecule Innovator CDMO Market Research Report 2025

Global Innovative Drug CDMO Market Research Report 2024

Global CMO and CDMO biotechnology Market Research Report 2024

Global Exosome CDMO Market Research Report 2024

Small Molecule CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Plasmid CDMO Services Market Research Report 2025

Global Microbial CDMO Service Market Research Report 2024

Global Cell and Gene Therapy CDMO Market Research Report 2024

Peptide CDMO Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Intermediate CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Cell Therapy CDMO Market Research Report 2024

Global Chemical Drug CDMO Market Research Report 2024

Global Cell Therapy CDMO Market Research Report 2025

Plasmid DNA CDMO Market

Active Pharmaceutical Ingredients CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical CDMO Pharmaceutical Contract Development and Manufacturing Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mammalian CDMO Service Market Research Report 2024

Softgel CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical CDMO Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions